(Q73221913)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11090695%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Flt3 ligand enhances the immunogenicity of a gag-based HIV-1 vaccine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11090695%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11090695%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

P Parajuli

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11090695%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

R L Mosley

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11090695%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J Sublet

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11090695%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

L Kelsey

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11090695%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

P S Sarin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11090695%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

D H Zimmerman

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11090695%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

M D Winship

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11090695%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J E Talmadge

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11090695%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 November 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11090695%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Immunopharmacology

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11090695%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11090695%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11090695%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

865-876

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11090695%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900048-5

7 January 2021

Progress in the development of an HIV-1 vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900048-5

7 January 2021

Neutralization of HTLV-III/LAV replication by antiserum to thymosin alpha 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900048-5

7 January 2021

Human immunodeficiency virus contains an epitope immunoreactive with thymosin alpha 1 and the 30-amino acid synthetic p17 group-specific antigen peptide HGP-30.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900048-5

7 January 2021

Preclinical and clinical studies on immunogenicity and safety of the HIV-1 p17-based synthetic peptide AIDS vaccine — HGP-30-KLH

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900048-5

7 January 2021

A TH1-->TH2 switch is a critical step in the etiology of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900048-5

7 January 2021

Cytotoxic T lymphocytes against HIV

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900048-5

7 January 2021

HIV preventive vaccines. Progress to date

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900048-5

7 January 2021

Candidate AIDS vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900048-5

7 January 2021

Progress in AIDS Vaccine Development

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900048-5

7 January 2021

Toward an understanding of the correlates of protective immunity to HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900048-5

7 January 2021

Cross-clade T cell recognition of HIV.1.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900048-5

7 January 2021

Random expression of human immunodeficiency virus-1 (HIV-1) p17 (epitopes) on the surface of the HIV-1-infected cell

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900048-5

7 January 2021

HGP-30, a synthetic analogue of human immunodeficiency virus (HIV) p17, is a target for cytotoxic lymphocytes in HIV-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900048-5

7 January 2021

Immune response and epitope mapping of a candidate hiv-1 p17 vaccine hgp30

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900048-5

7 January 2021

Booster immunization of HIV-1 negative volunteers with HGP-30 vaccine induces protection against HIV-1 virus challenge in SCID mice

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900048-5

7 January 2021

Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900048-5

7 January 2021

Antigen-unspecific B cells and lymphoid dendritic cells both show extensive surface expression of processed antigen-major histocompatibility complex class II complexes after soluble protein exposure in vivo or in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900048-5

7 January 2021

Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900048-5

7 January 2021

Human dendritic cells. Enrichment and characterization from peripheral blood

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900048-5

7 January 2021

Accessory cell requirements for the mixed-leukocyte reaction and polyclonal mitogens, as studied with a new technique for enriching blood dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900048-5

7 January 2021

Granulocyte-macrophage colony-stimulating factor promotes differentiation and survival of human peripheral blood dendritic cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900048-5

7 January 2021

Antigen-presenting cell types

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900048-5

7 January 2021

Dendritic cells: antigen presentation, accessory function and clinical relevance.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900048-5

7 January 2021

FLT3 ligand induces the generation of functionally active dendritic cells in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900048-5

7 January 2021

Induction of dendritic cells (DC) by Flt3 Ligand (FL) promotes the generation of tumor-specific immune responses in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900048-5

7 January 2021

Distinct dendritic cell subsets differentially regulate the class of immune response in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900048-5

7 January 2021

Prevention of peripheral tolerance by a dendritic cell growth factor: flt3 ligand as an adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900048-5

7 January 2021

Bioactive fragment of human IL-1beta [163-171] modulates the immune response to synthetic peptides of HIV

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900048-5

7 January 2021

Fully mobilizing host defense: building better vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900048-5

7 January 2021

Adjuvant effect of Ubenimex on a DNA vaccine for HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900048-5

7 January 2021

Delivery of liposome-encapsulated HIV type 1 proteins to human dendritic cells for stimulation of HIV type 1-specific memory cytotoxic T lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900048-5

7 January 2021

In vivo migration and function of transferred HIV-1-specific cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900048-5

7 January 2021

T(h)1 but not T(h)0 cell help is efficient to induce cytotoxic T lymphocytes by immunization with short synthetic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900048-5

7 January 2021

BCG-induced immunomodulation of DTH to heterologous erythrocytes leads to Mac-1-independent myelomonocytic cell recruitment.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900048-5

7 January 2021

Effective adjuvants for the induction of antigen-specific delayed-type hypersensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900048-5

7 January 2021

10.1016/S0192-0561(00)00048-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11090695%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference